Needham says Calix (CALX) reported Q4 above consensus and guided Q1 higher than expected as the company continues to execute well against its ...
In a report released today, Laura Martin from Needham maintained a Sell rating on Meta Platforms (META – Research Report). The company’s shares ...
SharkNinja, Inc. (NYSE: SN), a global product design and technology company, today announced that its financial results for the fourth quarter and fiscal year 2024 will be released on Thursday, ...
Calix (NYSE:CALX) shares maintained their Buy rating and $45.00 price target from Needham, following the company's fourth-quarter earnings results. Needham analysts highlighted Calix's revenue and non ...
Technological innovations in steam power, electricity and microprocessors drove the first industrial revolution.
Needham analysts maintained their Underperform rating on Meta Platforms Inc. (NASDAQ: NASDAQ:META), despite the company's strong performance in the fourth quarter of 2024. With a market capitalization ...
CEO Mattias Perjos said surgical perfusion has “been a struggling category” since an FDA consent decree forced Getinge off the U.S. market in 2015.